AXIM Biotechnologies, Inc.

AXIM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-Q Aug 22, 2016 FORM 10-Q QUARTERLY REPORT
8-K Aug 22, 2016 FORM 8-K CURRENT REPORT
NT 10-Q Aug 16, 2016 FORM12B25 NOTICE OF LATE FILING
10-Q/A May 26, 2016 FORM 10-Q A/1
10-Q May 23, 2016 FORM 10-Q
NT 10-Q May 13, 2016 FORM 12B-25
10-K/A Apr 18, 2016 FORM 10-K (A/1)
10-K Apr 14, 2016 FORM 10-K (12-31-15)
NT 10-K Mar 30, 2016 NT 10-K
8-K Feb 19, 2016 FORM 8-K
8-K Feb 8, 2016 FORM 8-K
4 Feb 5, 2016 PRIMARY DOCUMENT
4 Dec 30, 2015 PRIMARY DOCUMENT
4 Dec 30, 2015 PRIMARY DOCUMENT
10-Q Nov 23, 2015 FORM 10-Q (9-30-15)
NT 10-Q Nov 16, 2015 FORM 12B-25
8-K Sep 1, 2015 FORM 8-K
10-Q/A Aug 27, 2015 FORM 10-Q (A-1)
10-Q Aug 19, 2015 FORM 10-Q
NT 10-Q Aug 14, 2015 NT 10-Q
8-K Aug 6, 2015 FORM 8-K
8-K Jun 18, 2015 FORM 8-K
S-8 May 29, 2015 AXIM BIOTECHNOLOGIES, INC. 2015 STOCK INCENTIVE PLAN
8-K May 14, 2015 FORM 8-K
10-Q May 13, 2015 FORM 10-Q
← Newer Page 9 of 13 · 306 filings Older →